ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 658372 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 658372; 2) Community: the network communities that were significantly associated with the response to NSC 658372; 3) Molecule: the relationships between components within communities and NSC 658372; 4) MDR: the compounds that were significantly associated with the NSC 658372.

NSC Compound Enrichment Correlation
NSC 758662 Lovastatin [USAN] 0.0438391811600412 -0.080241576
NSC 78714 Clothixamide maleate (USAN) 0.0438391811600412 0.0149846
NSC 658874 Null 0.045446901295916 -0.14565103
NSC 661820 Null 0.045446901295916 0.37851522
NSC 673803 9-Acridinamine, N-[3-[bis(2-hydroxyethyl)amino]propyl]- 7-methoxy-3-nitro- 0.045446901295916 0.31014733
NSC 676775 Olean-12-en-28-oic acid, 3-.beta.-[2-O-(.beta.-D-glucopyranosyl)- .beta.-D-glucopyranosyloxy]-, [2-O-[[4-O-[3-O-(.beta.-L-arabinopyranosyl)- .beta.-D-xylopyranosyl]-3-O-.beta.-D-xylopyranosyl]- 6-deo 0.045446901295916 -0.21952284
NSC 680300 Null 0.045446901295916 0.13621416
NSC 684902 Null 0.045446901295916 0.30979054
NSC 690024 1,4-Butanediamine, N,N'-bis[3-[(phenylmethyl)amino]propyl]-,tetra(trifluoroacetate) 0.045446901295916 0.33698062
NSC 694002 2-Butenedioic acid, (E)-, 2-[3-[[[4-(acetyloxy)butyl]- 3H-1,2,3-triazol-4-yl]methyl]-1,2,3,4-tetrahydro-5-methyl-2,4-dioxo-1-pyrimidinyl]-, diethyl ester 0.045446901295916 0.20623981
Total:50  Current:41    [First] [Prev] [Next] [Last]